Sergey Brezgin

机构：Engelhardt Institute of Molecular Biology, Sechenov University, Genetic Technologies (Australia) · ORCID：0000-0003-4792-0739

发表论文 63 篇 · 总被引 1282 次 · h-index 19

代表论文

• CRISPR-Cas systems for diagnosing infectious diseases (2021 · Methods · 被引 179)
• Biomimetic Nanoparticles for Basic Drug Delivery (2024 · Pharmaceutics · 被引 60)
• Technological aspects of manufacturing and analytical control of biological nanoparticles (2023 · Biotechnology Advances · 被引 55)
• The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution (2024 · Medicinal Research Reviews · 被引 36)
• Biomimetic approaches for targeting tumor-promoting inflammation (2022 · Seminars in Cancer Biology · 被引 35)
• Depleting hepatitis B virus relaxed circular DNA is necessary for resolution of infection by CRISPR-Cas9 (2023 · Molecular Therapy — Nucleic Acids · 被引 34)